| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/17/24 | 8-K | Current report filing |
|
   |
7 |
| 07/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
55 |
| 06/11/24 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/11/24 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
16 | |
| 06/07/24 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 06/07/24 | UPLOAD | SEC-generated letter |
|
1 | |
| 06/03/24 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
27 | |
| 05/15/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/10/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/10/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.